Depreciation of Fulcrum Therapeutics, Inc. from 30 Jun 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Fulcrum Therapeutics, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Jun 2018 to 31 Dec 2025.
  • Fulcrum Therapeutics, Inc. Depreciation for the quarter ending 31 Dec 2025 was $437,000, a 39% increase year-over-year.
  • Fulcrum Therapeutics, Inc. Depreciation for the twelve months ending 31 Dec 2025 was $1,390,000, a 13% decline year-over-year.
  • Fulcrum Therapeutics, Inc. annual Depreciation for 2025 was $1,390,000, a 13% decline from 2024.
  • Fulcrum Therapeutics, Inc. annual Depreciation for 2024 was $1,593,000, a 27% decline from 2023.
  • Fulcrum Therapeutics, Inc. annual Depreciation for 2023 was $2,172,000, a 10% decline from 2022.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Fulcrum Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,390,000 $437,000 +$123,000 +39% 01 Oct 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
Q3 2025 $1,267,000 $300,000 -$100,000 -25% 01 Jul 2025 30 Sep 2025 10-Q 29 Oct 2025 2025 Q3
Q2 2025 $1,367,000 $300,000 -$100,000 -25% 01 Apr 2025 30 Jun 2025 10-Q 29 Jul 2025 2025 Q2
Q1 2025 $1,467,000 $353,000 -$126,000 -26% 01 Jan 2025 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $1,593,000 $314,000 -$192,000 -38% 01 Oct 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
Q3 2024 $1,785,000 $400,000 -$100,000 -20% 01 Jul 2024 30 Sep 2024 10-Q 29 Oct 2025 2025 Q3
Q2 2024 $1,885,000 $400,000 -$200,000 -33% 01 Apr 2024 30 Jun 2024 10-Q 29 Jul 2025 2025 Q2
Q1 2024 $2,085,000 $479,000 -$87,000 -15% 01 Jan 2024 31 Mar 2024 10-Q 01 May 2025 2025 Q1
Q4 2023 $2,172,000 $506,000 -$72,000 -12% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 $2,244,000 $500,000 -$100,000 -17% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $2,344,000 $600,000 -$100,000 -14% 01 Apr 2023 30 Jun 2023 10-Q 31 Jul 2024 2024 Q2
Q1 2023 $2,444,000 $566,000 +$30,000 +5.6% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $2,414,000 $578,000 -$34,000 -5.6% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 $2,448,000 $600,000 $0 0% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $2,448,000 $700,000 $0 0% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q1
Q1 2022 $2,448,000 $536,000 -$67,000 -11% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $2,515,000 $612,000 -$128,000 -17% 01 Oct 2021 31 Dec 2021 10-K/A 26 Jun 2023 2022 FY
Q3 2021 $2,643,000 $600,000 +$100,000 +20% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $2,543,000 $700,000 +$100,000 +17% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $2,443,000 $603,000 +$64,000 +12% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $2,379,000 $740,000 +$191,000 +35% 01 Oct 2020 31 Dec 2020 10-K/A 26 Jun 2023 2021 FY
Q3 2020 $2,188,000 $500,000 $0 0% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $2,188,000 $600,000 +$100,000 +20% 01 Apr 2020 30 Jun 2020 10-Q 10 Aug 2021 2021 Q2
Q1 2020 $2,088,000 $539,000 +$35,000 +6.9% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $2,053,000 $549,000 01 Oct 2019 31 Dec 2019 10-K/A 23 Jun 2023 2020 FY
Q3 2019 $500,000 +$100,000 +25% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $500,000 +$300,000 +150% 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020 2020 Q2
Q1 2019 $504,000 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q3 2018 $400,000 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019 2019 Q3
Q2 2018 $200,000 01 Apr 2018 30 Jun 2018 10-Q 26 Aug 2019 2019 Q2

Fulcrum Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,390,000 -$203,000 -13% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $1,593,000 -$579,000 -27% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $2,172,000 -$242,000 -10% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2025 2024 FY
2022 $2,414,000 -$101,000 -4% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2024 2023 FY
2021 $2,515,000 +$136,000 +5.7% 01 Jan 2021 31 Dec 2021 10-K/A 26 Jun 2023 2022 FY
2020 $2,379,000 +$326,000 +16% 01 Jan 2020 31 Dec 2020 10-K/A 26 Jun 2023 2021 FY
2019 $2,053,000 +$708,000 +53% 01 Jan 2019 31 Dec 2019 10-K/A 23 Jun 2023 2020 FY
2018 $1,345,000 01 Jan 2018 31 Dec 2018 10-K 05 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.